About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

RNA-Based Drugs Give More Control Over Gene Editing Activity

by Dr. Trupti Shirole on January 20, 2016 at 12:51 AM
Font : A-A+

 RNA-Based Drugs Give More Control Over Gene Editing Activity

In just the past few years, researchers have found a way to use a naturally occurring bacterial system known as CRISPR/Cas9 to inactivate or correct specific genes in any organism. CRISPR/Cas9 gene editing activity runs continuously, though, leading to risk of additional editing at unwanted sites.

Now, researchers at University of California, San Diego School of Medicine, Ludwig Cancer Research and Isis Pharmaceuticals demonstrate a commercially feasible way to use RNA to turn the CRISPR-Cas9 system on and off as desired - permanently editing a gene, but only temporarily activating CRISPR-Cas9. The study is published by Proceedings of the National Academy of Sciences.

Advertisement


"These findings provide a platform for multiple therapeutic applications, especially for nervous system diseases, using successive application of designer CRISPR RNA drugs," said senior author Don Cleveland, Ludwig San Diego Member and Distinguished Professor and Chair of the Department of Cellular and Molecular Medicine at UC San Diego School of Medicine.

The conventional CRISPR-Cas9 system comprises two parts: the Cas9 enzyme, which acts like a wrench, and specific RNA guides (CRISPRs), which act as different socket heads. These RNAs guide the Cas9 protein to the target gene on a DNA strand. This technique allows researchers to study genes in a specific, targeted way.
Advertisement

CRISPR/Cas9 works like this - researchers design a 'guide' RNA to match the sequence of a specific target gene. The RNA guides the Cas9 enzyme to the desired spot, where it cuts the DNA. The cell can repair the DNA break, but it does so imprecisely, thereby inactivating the gene. Alternatively, researchers can coax the cell into replacing the section adjacent to the cut with a healthier version of the gene. Researchers are now testing the CRISPR/Cas9 system in a variety of applications to repair defective genes that cause disease.

The new approach introduces chemically modified, RNA-based drugs to transiently activate the CRISPR/Cas9 gene editing system. An initial, specially modified RNA is used to replace the usual guide RNA. This RNA directs Cas9's DNA-cutting activity to a selected target gene and the editing process proceeds. Activity is transient, however, as the editing stops when the guiding RNA drug is cleared. An extension of the approach can switch off the molecular scissors even faster by addition of a second, chemically modified RNA drug that directs inactivation of the gene encoding the Cas9 enzyme.

"The RNA-based drugs we developed in this study provide many advantages over the current CRISPR/Cas9 system, such as increased editing efficiency and potential selectivity. "In addition, they can be synthesized efficiently, on an industrial scale and in a commercially feasible manner today," said Cleveland

"Today's published work is another demonstration of the successful synergy between Dr. Cleveland's lab and my team at Isis Pharmaceuticals," said C. Frank Bennet, co-senior author of the study and senior vice president of research at Isis Pharmaceuticals. "Leveraging Isis' expertise in developing RNA-targeted compounds, together the team has demonstrated that we can develop molecules that enhance the effectiveness of the CRISPR mechanism."

Source: Newswise
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Alarming Cesarean Section Trends in India - Convenience or Compulsion of Corporate Healthcare
Quiz on Low-Calorie Diet for Diabetes
World Heart Day in 2022- Use Heart for Every Heart
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
DNA Finger Printing Drug Toxicity Drugs Banned in India Weaver Syndrome 

Most Popular on Medindia

Drug - Food Interactions Diaphragmatic Hernia Blood Pressure Calculator Iron Intake Calculator Calculate Ideal Weight for Infants Find a Hospital Noscaphene (Noscapine) Daily Calorie Requirements How to Reduce School Bag Weight - Simple Tips The Essence of Yoga
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
×

RNA-Based Drugs Give More Control Over Gene Editing Activity Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests